Work

Clinical outcome of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with a post-treatment circulating tumor cell (CTC) of 0 vs CTC > 0: Post hoc analysis of COU-AA-301.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.5015

Authors: Howard I. Scher, Glenn Heller, Margaret K. Yu, Thian Kheoh, Weimin Peng, Johann S. De Bono

Institutions: Memorial Sloan Kettering Cancer Center, Institute of Cancer Research, Royal Marsden Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891952750

Cites:

Cited by: 2

Related to: 10